Literature DB >> 8104891

Oligodendroglial lineage cells express neuroligand receptors.

C H Kastritsis1, K D McCarthy.   

Abstract

This study was designed to determine whether cells of the oligodendroglial lineage express neuroligand receptors linked to Ca2+ mobilization. Intracellular Ca2+ levels were monitored with a video-based imaging system and cells were characterized with immunocytochemical markers. O-2A progenitor cells (A2B5+/GFAP-) and mature oligodendroglia (GC+/MBP+) responded to norepinephrine, glutamate, ATP, and histamine with increased intracellular Ca2+ levels. As O-2A progenitor cells differentiated into mature oligodendroglia, there was an increase in the percentage of cells that responded to ATP and histamine with an increase in intracellular Ca2+ levels. Both O-2A progenitor cells and mature oligodendroglia were pharmacologically heterogeneous with respect to their ability to respond to neuroligands with an increase in intracellular Ca2+. Treatment with bradykinin, carbachol, and substance P also increased intracellular Ca2+ levels in O-2A progenitor cells and mature oligodendroglia. Whereas the percentage of cells that responded to bradykinin and substance P increased with differentiation of O-2A progenitor cells into mature oligodendroglia, the trend was reversed with respect to the percentage of cells responding to carbachol. These results suggest that cells of the oligodendroglial lineage exhibit neuroligand receptors linked to Ca2+ mobilization and that the ability of these cells to respond to neuroligands is developmentally regulated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104891     DOI: 10.1002/glia.440080206

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  17 in total

1.  Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials.

Authors:  Beth Stevens; Stefania Porta; Laurel L Haak; Vittorio Gallo; R Douglas Fields
Journal:  Neuron       Date:  2002-12-05       Impact factor: 17.173

2.  Sparks and puffs in oligodendrocyte progenitors: cross talk between ryanodine receptors and inositol trisphosphate receptors.

Authors:  L L Haak; L S Song; T F Molinski; I N Pessah; H Cheng; J T Russell
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 3.  Purinergic signalling in neuron-glia interactions.

Authors:  R Douglas Fields; Geoffrey Burnstock
Journal:  Nat Rev Neurosci       Date:  2006-06       Impact factor: 34.870

4.  A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.

Authors:  C Ho; J Hicks; M W Salter
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 5.  Electrophysiological properties of NG2(+) cells: Matching physiological studies with gene expression profiles.

Authors:  Valerie A Larson; Ye Zhang; Dwight E Bergles
Journal:  Brain Res       Date:  2015-09-15       Impact factor: 3.252

Review 6.  Purinergic signaling in oligodendrocyte development and function.

Authors:  Taylor G Welsh; Sarah Kucenas
Journal:  J Neurochem       Date:  2018-03-25       Impact factor: 5.372

Review 7.  Neuron-oligodendroglia interactions: Activity-dependent regulation of cellular signaling.

Authors:  Michael A Thornton; Ethan G Hughes
Journal:  Neurosci Lett       Date:  2020-03-16       Impact factor: 3.046

8.  Effects of glutamate receptor activation on NG2-glia in the rat optic nerve.

Authors:  Nicola Hamilton; Paul S Hubbard; Arthur M Butt
Journal:  J Anat       Date:  2009-02       Impact factor: 2.610

Review 9.  Neuronal Activity-Dependent Control of Postnatal Neurogenesis and Gliogenesis.

Authors:  Ragnhildur T Káradóttir; Chay T Kuo
Journal:  Annu Rev Neurosci       Date:  2018-04-04       Impact factor: 12.449

Review 10.  Intertwining extracellular nucleotides and their receptors with Ca2+ in determining adult neural stem cell survival, proliferation and final fate.

Authors:  Davide Lecca; Marta Fumagalli; Stefania Ceruti; Maria P Abbracchio
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.